Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | LMNA | P02545 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | F2 | P00734 | 2/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.33 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16347736 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNAKMT2AMAPTMEN1 | |
| SCHEMBL6890184 | 0.69 | ALDH1A1 (0.36) | ALDH1A1LMNAKMT2AMAPTMEN1 | |
| SCHEMBL4505355 | 0.67 | MEN1 (0.32) | ALDH1A1LMNAKMT2AMAPTMEN1 | |
| SCHEMBL7580955 | 0.67 | MEN1 (0.32) | ALDH1A1LMNAKMT2AMAPTMEN1 | |
| Camphor SCHEMBL2037672 | 0.64 | ALDH1A1 (1.00) | ALDH1A1LMNAKMT2AMAPTMEN1 | |
| Camphor SCHEMBL16068 | 0.64 | ALDH1A1 (1.00) | ALDH1A1LMNAKMT2AMAPTMEN1 | |
| (-)-Camphor SCHEMBL1701376 | 0.64 | ALDH1A1 (1.00) | ALDH1A1LMNAKMT2AMAPTMEN1 | |
| Camphor SCHEMBL285280 | 0.64 | ALDH1A1 (1.00) | ALDH1A1LMNAKMT2AMAPTMEN1 | |
| Camphor SCHEMBL15542393 | 0.64 | ALDH1A1 (1.00) | ALDH1A1LMNAKMT2AMAPTMEN1 | |
| Camphor SCHEMBL1151878 | 0.64 | ALDH1A1 (1.00) | ALDH1A1LMNAKMT2AMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060111270-A1 | Ketocampholenic acid derivatives and their use in fragrance applications | AROMAGEN CORPORATION | 2006-05-25 | — | — | US | claimed |
| EP-1534660-A1 | KETOCAMPHOLENIC ACID DERIVATIVES AND THEIR USE IN FRAGRANCE AND FLAVOR APPLICATIONS | Aromagen Corporation (US) | 2005-06-01 | — | — | EP | claimed |
| WO-2004013079-A1 | KETOCAMPHOLENIC ACID DERIVATIVES AND THEIR USE IN FRAGRANCE AND FLAVOUR APPLICATIONS | AROMAGEN CORPORATION (US) | 2004-02-12 | — | — | WO | claimed |
| EP-2636665-B1 | METHOD FOR PRODUCING ESTER | UNIV NAGOYA NAT UNIV CORP (JP) | 2016-06-22 | — | — | EP | disclosed |
| WO-2015000076-A9 | PHOTOCHEMICAL PROCESS FOR THE FLUORINATION OF AN ORGANIC COMPOUND HAVING AN UNACTIVATED SP3 C-H BOND | ALECTOS THERAPEUTICS INC. (CA) | 2015-08-06 | — | — | WO | disclosed |
| WO-2015000076-A9 | PHOTOCHEMICAL PROCESS FOR THE FLUORINATION OF AN ORGANIC COMPOUND HAVING AN UNACTIVATED SP3 C-H BOND | ALECTOS THERAPEUTICS INC. (CA) | 2015-08-06 | — | — | WO | disclosed |
| WO-2015000076-A1 | PHOTOCHEMICAL PROCESS FOR THE FLUORTNATION OF AN ORGANIC COMPOUND HAVING AN UNACTIVATED SP3 C-H BOND | ALECTOS THERAPEUTICS INC. (CA) | 2015-01-08 | — | — | WO | disclosed |
| WO-2015000076-A1 | PHOTOCHEMICAL PROCESS FOR THE FLUORTNATION OF AN ORGANIC COMPOUND HAVING AN UNACTIVATED SP3 C-H BOND | ALECTOS THERAPEUTICS INC. (CA) | 2015-01-08 | — | — | WO | disclosed |
| US-8853426-B2 | Method for manufacturing ester | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2014-10-07 | — | — | US | disclosed |
| US-8853426-B2 | Method for manufacturing ester | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2014-10-07 | — | — | US | disclosed |
| US-20130217898-A1 | METHOD FOR MANUFACTURING ESTER | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2013-08-22 | — | — | US | disclosed |
| US-20130217898-A1 | METHOD FOR MANUFACTURING ESTER | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2013-08-22 | — | — | US | disclosed |
| US-20060111270-A1 | Ketocampholenic acid derivatives and their use in fragrance applications | AROMAGEN CORPORATION | 2006-05-25 | — | — | US | disclosed |
| EP-1534660-A1 | KETOCAMPHOLENIC ACID DERIVATIVES AND THEIR USE IN FRAGRANCE AND FLAVOR APPLICATIONS | Aromagen Corporation (US) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004013079-A1 | KETOCAMPHOLENIC ACID DERIVATIVES AND THEIR USE IN FRAGRANCE AND FLAVOUR APPLICATIONS | AROMAGEN CORPORATION (US) | 2004-02-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130217898-A1 | METHOD FOR MANUFACTURING ESTER | CBR3, BCKDK, ACSL4 | ALDH1A1 1584/4885LMNA 3011/4885KMT2A 2453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.